Teleflex completes enrollment in BIOMAG-LL magnesium scaffold study

Go back to Teleflex completes enrollment in BIOMAG-LL magnesium scaffold study

Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold

October 12, 2026 6:30 AM EDT

102 patients enrolled across 14 European centers to assess safety and clinical performance of 35 mm and 40 mm Freesolve Resorbable Magnesium Scaffolds in long coronary lesions

WAYNE, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the successful completion of patient enrollment in the... More